Neurovanda Therapeutics

NeuroVanda is a Singapore-based biotech developing transformational therapies for neurodegenerative diseases. We achieve this by leveraging deep insights in disease mechanism, employing disease-relevant models and pairing the best-suited therapeutic modalities with the most pertinent targets Our team consists of world-renowned scientific founders from the University of Pennsylvania, Weill Cornell Medical Colleague and University of California, San Francisco. NeuroVanda leverages translational models that have been developed over decades in the labs of our scientific founders and are guided by deep expertise to further establish pathophysiologically relevant models. The NeuroVanda team comprises experienced drug hunters who have deep expertise in developing novel modalities such as protein degraders to tackle the most pertinent targets.